1046. Deputy Ken O'Flynn asked the Minister for Health the total number of rejected or unpaid pharmacy claims recorded under the General Medical Services Scheme in each year from 2020 to 2026, in tabular form [36795/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Ken O'Flynn under the heading Pharmacy Services.
21 questions match, newest first.
1047. Deputy Ken O'Flynn asked the Minister for Health the most common categories of rejected pharmacy claims under the General Medical Services Scheme in each year since 2020. [36796/26]
1048. Deputy Ken O'Flynn asked the Minister for Health whether the HSE records the number of rejected claims relating specifically to respiratory medications including salbutamol, ipratropium, steroid inhalers and nebuliser products. [36797/26]
1049. Deputy Ken O'Flynn asked the Minister for Health whether any audit, review, or risk assessment has been conducted examining the patient safety implications of rejected pharmacy claims under the PCRS system in the past five years. [36798/26]
1050. Deputy Ken O'Flynn asked the Minister for Health whether pharmacies are financially disadvantaged where claims are repeatedly rejected due to software or administrative validation issues. [36799/26]
1073. Deputy Ken O'Flynn asked the Minister for Health whether any assessment has been carried out into the financial impact of rejected pharmacy claims on community pharmacies. [36914/26]
603. Deputy Ken O'Flynn asked the Minister for Health whether her Department has conducted a formal risk assessment of the requirement that dispensing pharmacies must contact the primary care reimbursement service on a case-by-case basis to secure reimbursement approval for clinically equivalent substitute medicines during a formally declared shortage; whether any patient-safety analysis has been undertaken regarding…
606. Deputy Ken O'Flynn asked the Minister for Health whether her Department has assessed the administrative burden placed on community pharmacies in circumstances where substitute reimbursement must be individually queried with the Primary Care Reimbursement Service; whether any review has been undertaken of processing times, approval rates or rejected applications in such cases over the past three years; and if she…
610. Deputy Ken O'Flynn asked the Minister for Health whether any equity impact assessment has been conducted to determine whether patients without medical cards or without established drugs payment scheme eligibility face additional barriers in accessing substitute medicines during shortages; and whether she will outline any measures in place to prevent differential access arising from reimbursement mechanisms. [13…
1138. Deputy Ken O'Flynn asked the Minister for Health whether her Department or the HSE has carried out any clinical risk assessment of patients with disabilities, cognitive impairment, or home-care dependency who rely on pharmacist-prepared monitored dosage systems to safely self-administer prescribed medicines; if so, the date of such assessment; the persons that conducted it; and if she will publish the findings.…
1139. Deputy Ken O'Flynn asked the Minister for Health whether any equality or disability impact assessment has been undertaken in respect of the exclusion of pharmacist-prepared monitored dosage systems from State funding under the long-term illness scheme, having regard to obligations to provide reasonable accommodation for persons with disabilities; and if not, when such an assessment will be initiated. [12153/26]
1140. Deputy Ken O'Flynn asked the Minister for Health the clinical or professional guidance her Department relies upon when stating that monitored dosage systems should be used only as a last resort; the source of that guidance; whether it has been formally adopted in Ireland; and if she will confirm whether any Irish clinical standard governs access to medication compliance supports for vulnerable patients living i…
324. Deputy Ken O'Flynn asked the Minister for Health whether her Department recognises that, for some people with disabilities and people receiving home-care supports, pharmacist-prepared monitored dosage systems, including blister packs, are clinically required to ensure safe medication administration and compliance; whether any national clinical guidance, policy circular, or Department-approved criteria exist to d…
325. Deputy Ken O'Flynn asked the Minister for Health whether her Department has undertaken, or commissioned, any patient safety or risk assessment regarding the withdrawal or non-funding of pharmacist-prepared blister packs for people with disabilities or cognitive impairment who rely on such supports in a home-care setting; the findings of any such assessment; and if none has been undertaken, when such an assessmen…
326. Deputy Ken O'Flynn asked the Minister for Health whether her Department has carried out a disability impact assessment, equality impact assessment, or human rights analysis in respect of the non-funding of monitored dosage systems, including blister packs, under the long-term Illness scheme; and if she will confirm whether the implications for people with disabilities living independently or with home-care suppo…
327. Deputy Ken O'Flynn asked the Minister for Health when her Department first became aware that monitored dosage systems, including blister packs, were being provided to patients in practice while pharmacies claimed phased dispensing fees; the policy, governance, or compliance actions that were taken by her Department at that time; and if she will outline the Department’s oversight responsibilities in respect of en…
328. Deputy Ken O'Flynn asked the Minister for Health what interim safeguards or guidance have been issued by her Department to ensure that patients with disabilities or complex medication needs do not experience disruption to medication compliance supports during the current pause in changes to phased dispensing arrangements; and whether clinicians or pharmacists have discretion to continue such supports where clini…
329. Deputy Ken O'Flynn asked the Minister for Health the mechanism that exist, or are being considered, whereby a clinician, pharmacist, or multidisciplinary care team may formally certify that monitored dosage systems, including blister packs, are clinically necessary for an individual patient; and whether such certification would permit continued provision without cost to the patient under existing schemes. [10673…
330. Deputy Ken O'Flynn asked the Minister for Health the way in which the non-funding of pharmacist-prepared blister packs aligns with national home-care policy objectives that support independent living for people with disabilities and older persons; and whether her Department accepts that medication compliance supports form an integral part of safe home-based care. [10674/26]
331. Deputy Ken O'Flynn asked the Minister for Health when her Department’s examination of the use of monitored dosage systems, including blister packs, will conclude; whether formal policy proposals will be published; and if she will commit to ensuring that any future framework explicitly addresses the needs of people with disabilities and those receiving home-care supports. [10675/26]
2298. Deputy Ken O'Flynn asked the Minister for Health to confirm whether prescriptions can be issued for a six-month period, or longer, under current legislation (details supplied). [20139/25]